Gudang Garam Stock Continues to Decline in Indonesia's Anti-Smoking Campaign

Dec.08.2022
Gudang Garam Stock Continues to Decline in Indonesia's Anti-Smoking Campaign
Susilo Wonowidjojo's wealth declined due to falling stocks of his family's cigarette company, Gudang Garam, amid anti-smoking campaigns.

Susilo Wonowidjojo's wealth has further declined this year as the stock of his family's cigarette manufacturer Gudang Garam continues its three-year slump amid the Indonesian government's anti-smoking campaign. His net worth dropped by 27% to $3.5 billion, placing him at 14th on Indonesia's richest 50 list, down seven spots from last year.


Despite a slight improvement in sales during the first nine months of 2022, net profit has decreased by 64% year-on-year to 15 trillion Indonesian rupiahs (96 million US dollars), primarily due to the government's increase in tobacco consumption tax in January (following a 27% drop in revenue in 2021). Taxes make up over 85% of the company's total sales costs, resulting in a profit margin of 1.6%, down from 4.4% last year. Additionally, in November, Finance Minister Sri Mulyani Indrawati announced additional tax increases in 2023 and 2024. The company has stated its plans to raise prices.


In recent years, Indonesia has strengthened its measures to combat smoking, especially among young people. Approximately one quarter of the country's 276 million population smoke cigarettes. Overseas sales for Gudang Garam have also declined, dropping nearly 15% year-on-year in 2021 to 1.8 billion cigarettes. The company diversified its operations in 2019 with the construction of toll roads and is currently building the Dhoho airport in Kediri, East Java at a cost of 600 million dollars, which is expected to open in October of next year.


Gudang Garam was founded in 1958 by Susilo's father, Surya Wonowidjojo. Since 2009, Susilo has served as the CEO of the Kediri-based company, with his sister Juni Setiawati serving as the executive commissioner. In June, Susilo's son Indra was appointed as the Vice President Director.


2FIRSTS will continue to report on this issue, with further updates available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Shenzhen tobacco authorities have asked licensed Chinese vape manufacturers to submit STN details for U.S.-bound products, including CTP Portal or STN email screenshots, highlighting a new compliance signal in cross-border oversight.
Apr.02
Hillsborough County Public Schools to install vaping detection sensors across all high schools
Hillsborough County Public Schools to install vaping detection sensors across all high schools
Hillsborough County Public Schools (HCPS) announced it will install vaping detection sensors across all high schools in Hillsborough County as part of what officials called a “proactive step” toward healthier and safer learning environments. District staff said the sensors are intended to help reduce vaping on campus, support student well-being and encourage positive behavior change.
Feb.26 by 2FIRSTS.ai
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
India has reaffirmed its 2019 ban on e-cigarettes and heated tobacco devices, effectively blocking Philip Morris International (PMI) from launching IQOS in the country despite years of lobbying. Together with Taiwan, China’s conditional opening of heated tobacco products, and Japan’s planned 2026 excise tax hikes, these moves highlight increasingly divergent national regulatory pathways—an external uncertainty shaping PMI’s smoke-free growth trajectory.
Feb.12